Drug
Warfarin 3mg
Warfarin 3mg is a pharmaceutical drug with 3 clinical trials. Historical success rate of 33.3%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
300%(3 trials)
Terminated
2(67%)
Phase Distribution
Ph phase_2
2
67%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
Phase 3Large-scale testing
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Terminated2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
33.3%
Most Advanced
Phase 3
Trials by Phase
Phase 22 (66.7%)
Phase 31 (33.3%)
Trials by Status
terminated267%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_3
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
NCT02164864
terminatedphase_2
Dabigatran Etexilate in Patients With Mechanical Heart Valves
NCT01452347
terminatedphase_2
Follow on Study From RE-ALIGN
NCT01505881
Clinical Trials (3)
Showing 3 of 3 trials
NCT02164864Phase 3
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
NCT01452347Phase 2
Dabigatran Etexilate in Patients With Mechanical Heart Valves
NCT01505881Phase 2
Follow on Study From RE-ALIGN
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3